Results 151 to 160 of about 924 (199)

Classification and applicability of new beta-lactamase inhibitors. [PDF]

Rev Esp Quimioter
Cercenado E, Candel FJ.
europepmc   +1 more source

Integrative review on Acinetobacter baumannii as a multidrug-resistant pathogen: resistance mechanisms and therapeutic perspectives in the context of nosocomial infections. [PDF]

Rev Soc Bras Med Trop
Lima PHM, Lopes CF, Freire JPC, Feliciano LD, Amorim RCO, Mota ML, Cirqueira FF, Lemos FFB, Pedroso SHSP, Melo FF.   +9 more
europepmc   +1 more source

New Insights into <i>Acinetobacter baumannii</i> Pathogenesis and Therapeutic Implications. [PDF]

Pathogens
Morena R, Morrone HL, Olivadese V, Gullì SP, Serapide F, Russo A.   +5 more
europepmc   +1 more source

Treating Extensively Drug-Resistant Acinetobacter baumannii: Considerations for Host Characteristics and Type of Infections. [PDF]

Pathogens
Geladari A, Kouroupis D, Vafeidou K, Liakos V, Magoudi M, Papathanasiou AI, Iosifidis E, Roilides E, Antachopoulos C, Pyrpasopoulou A.   +9 more
europepmc   +1 more source

<i>Acinetobacter baumannii</i> treatment strategies: a review of therapeutic challenges and considerations. [PDF]

Antimicrob Agents Chemother
Kubin CJ, Garzia C, Uhlemann A-C.
europepmc   +1 more source

Introduction to XIV updating course of antimicrobials and infectious diseases. [PDF]

Rev Esp Quimioter
Candel FJ, Matesanz M.
europepmc   +1 more source

AMRrounds: Carbapenem-resistant <i>Acinetobacter baumannii</i> in the intensive care unit-when resistance meets severity. [PDF]

JAC Antimicrob Resist
Mangioni D, Abbruzzese C, Teri A, Bonaiuto C, Pecere A, Alteri C, Canetta C, Muscatello A, Rossolini GM, Callegaro A, Grasselli G, Sottocorno M, Panigada M, Bandera A.   +13 more
europepmc   +1 more source